Seasonal influenza has an estimated global reach of 3 to 5 million infections with 290 000 to 650 000 influenza-related deaths yearly. Despite its efficacy in reducing morbidity and mortality, influenza vaccination rates remain low globally and in South Africa. Youth between the ages of 18-34 years are not prioritised for influenza vaccines although influenza surveillance in South Africa shows that individuals aged 19 to 44 present the highest asymptomatic episodes and the lowest medically attended illness. This creates an opportunity to investigate if and how vaccine demand can be created in the absence of clear imperatives to vaccinate. The study tests the effectiveness of tailored, context-specific education, community engagement, including community and social media to increase influenza vaccination uptake. Tailored, context-specific education, community engagement, reliable vaccine supply and free, localised access are all critical for improving perceptions of, increasing confidence in, and motivating uptake of vaccination. This study explores strategies to increase vaccine uptake amongst marginalised youth 18-34 years old in Soweto, South Africa, where influenza vaccines are not universally accessible through the public health system for this age group.   Methods The Bambisana Study uses an innovative approach - including community influencers and social media - to increase uptake of influenza vaccines through designing and testing an integrated communications strategy targeted at marginalised youth in Soweto, South Africa. The Bambisana study uses a mixed methods pre-test, post-test intervention design to test the effects of the interventions. Conclusion and Significance Enhancing perceptions of, bolstering confidence in, and fostering uptake of vaccination relies heavily on the efficacy of yearly influenza vaccination initiatives, personalized education tailored to specific contexts, active community involvement, consistent vaccine availability, and easily accessible, cost-free distribution channels at the local level.

The authors have declared no competing interest.

Yes

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

University of the Witwatersrand

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Protocol Paper therefore no data reported